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Abstract
Background: Epithelioid sarcoma (ES) is an uncommon soft tissue sarcoma. Lately, subtypes of
ES, including proximal-type ES have been recognized, with relatively few reports on such cases.
Case presentation: A 47-year-old male presented with a perineal soft tissue mass that was
excised elsewhere and the biopsy was submitted for a review diagnosis. On histology, a multi
nodular tumor was seen comprising sheets of oval to polygonal cells with moderate amount of
cytoplasm. Interspersed were larger, rhabdoid cells with abundant eosinophilic cytoplasm and
prominent nucleoli. Focal necrosis was noted. A wide panel of immunohistochemical (IHC)
markers was performed to rule out a range of differential diagnoses, including a poorly
differentiated carcinoma, a melanoma and a variety of sarcomas with epithelioid differentiation. On
IHC, the tumor cells showed a polyphenotypic expression, including positivity for epithelial
markers i.e cytokeratin (CK), CK7, EMA and mesenchymal markers like vimentin and CD 34.
Desmin was focally positive. CK20, CEA, S-100, HMB-45, SMA, LCA and CD31 were negative. A
diagnosis of a proximal-type ES was formed. Six moths later, despite adjuvant chemo and
radiotherapy (CT and RT), the patient continued to have the lesion and was referred again. In
addition to the earlier histological features, sections from the persistent tumor mass showed an
increased number of larger cells along with multinucleated tumor giant cells.
Conclusion: The value of identifying this uncommon tumor from a list of differential diagnoses is
in view of its aggressive behavior, as seen in our case. A wide excision with clear margins is
imperative with options of post-operative CT/RT in individual cases during a close follow-up.
Background
Epithelioid sarcoma (ES) is an uncommon soft tissue sar-
coma, first described as an independent entity by Enzinger
[1]. This is usually a slow growing tumor and mostly
occurs in the dermal or subcutaneous area of the distal
extremities of young adults. It has a tendency for develop-
ment of local recurrences and metastasis thereafter, which
has been seen in 40–45% cases. Apart from the conven-
tional type of ES, fibrous histiocytoma-like and angioma-
toid subtypes have also been noted [2,3]. Lately, an
aggressive subtype of ES has been identified known as the
"proximal-type/axial-type" [4]. We present this uncom-
mmon tumor in a middle-aged male, who presented with
a perineal mass. The diagnosis is discussed in the light of
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available literature along with a wide range of differentials
that were considered.
Case presentation
A 47-year-old male presented with a gradually increasing,
painful soft tissue mass of 7–8 months duration, measur-
ing 4 × 3 cm in the inner side of his right thigh. A com-
puted tomogram (CT) scan revealed an abnormal
enhancing lesion in the perianal region. All the visceral
organs were found to be normal. No bowel wall thicken-
ing, free fluid or abdominal lymphadenopathies were
noticed.
Subsequently, he underwent a marginal excision for this
mass, elsewhere. It was diagnosed as a poorly differenti-
ated carcinoma on biopsy and referred to us in form of a
single hematoxylin and eosin (H & E) stained micro sec-
tion along with a paraffin block for review.
At our Hospital, his tumor marker levels for carcino
embryogenic antigen (CEA) were normal i.e. 1.8 ng/ml
(normal range: 0.3–2.7 ng/ml)
On review histology, a diagnosis of a "proximal-type" epi-
thelioid sarcoma was offered. The patient was recom-
mended a wide excision post a magnetic resonance
imaging (MRI) for fear of residual disease. However, he
was lost to follow-up.
Six moths later, he presented with an enlarging mass at the
same location. During this time gap, he revealed a history
of having undergone adjuvant chemotherapy (CT) and
radiotherapy (RT) that were well tolerated. However, he
developed difficulty in walking as a result of the persistent
lesion. He underwent a chest X-ray along with CT scan
and a real time B-mode high frequency ultrasonographic
(USG) examination for the persistent mass that was re-
excised and re-submitted to us for review.
Ultrasonographic (USG) findings
An oval, hypoechoic, solid lesion measuring 2.9 × 2.2 ×
2.1 cms was seen in the deep subcutaneous region of the
right, upper, inner thigh up to 5–10 mm superior and
anterior to the scar of the earlier excision. Other, two,
small oval hypoechoic solid lesions of sizes 10 and 8 mm
were seen in the subcutaneous layer. The main lesion
showed an ill-defined echogenic wall with peripheral
echogenic linear echo entering the lesion, suggestive for a
lymph node. Eccentric cortical parenchyma showed a dis-
torted architecture. The overlying skin was normal with
slightly prominent subcutaneous fat lobules. No signifi-
cant flow lesion was seen in the color Doppler. Radiolog-
ically, the differential diagnoses included a tumor mass vs
a lymph node mass. (Figure 1).
Histopathological findings
Grossly, the first excision specimen was in form of grey-
white soft tissue bits aggregating to 3.5 × 2 × 2 cms. Details
regarding the marginal status were unavailable.
Microscopic findings
On histology, the tumor revealed a multi nodular pattern
as a result of investing thin fibrous septa with cells pre-
dominantly arranged in a cohesive manner. At places cel-
lular disintegration was observed in combination with
hemorrhage resulting in a 'pseudoangiosarcomatous' pat-
tern. The cells were oval to polygonal and exhibited mod-
erate nuclear pleomorphism. Interspersed were larger cells
with vesicular nuclei, prominent nucleoli and abundant
cytoplasm, including intracytoplasmic inclusions remi-
niscent of a 'rhabdoid' morphology along with focal areas
of tumoral necrosis. Mitoses were noted, however, not
conspicuously. (Figure 2A, 2B, and 2C).
Special histochemical stains were carried out with a wide
panel of IHC markers (Table 1). The reticulin staining
highlighted the nodular growth pattern of the tumor. (Fig-
ure 2D). IHC showed a diffuse strong positivity for CK
and vimentin in the tumor cells. CK-7 and EMA were also
strongly positive. (Figure 3A and 3B). Desmin was focally
positive (Figure 3C). In addition, CD34 was found to be
strongly positive (Figure 3D). SMA, Myo-D1, CK-20, CEA,
S-100, HMB-45, CD 31, C-kit and LCA were negative. A
diagnosis of a proximal-type epithelioid sarcoma of was
formed.
The re-excision showed a similar histology. In addition,
increased number of larger cells was noticed along with
tumor giant cells and several mitoses.
Discussion
A conventional-type epithelioid sarcoma (ES) it is mostly
seen in the distal extremities (commonly hand) of young
adults. On histomorphology, it displays a typical "granu-
loma-like" pattern of tumor cells surrounding a necrotic
focus [1].
Lately, a non-conventional subtype of ES has been identi-
fied with a differing clinical profile and a polyphenotypic
differentiation, termed as the "proximal-type" ES. It is
more frequently seen in the pelvis, perineum and genital
tract of young to middle aged adults. On histology, it usu-
ally lacks the conventional "granuloma-like appearance".
In addition to presence of oval to polygonal cells, it shows
characteristic large cells with 'rhabdoid' traits [4].
The present case was identified as a perineal mass in a
middle-aged male. The outside slide on review revealed a
multi nodular tumor comprising oval to polygonal cells
arranged predominantly in cohesive sheet like pattern.World Journal of Surgical Oncology 2007, 5:28 http://www.wjso.com/content/5/1/28
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Interspersed were large cells with abundant cytoplasm,
vesicular nuclear chromatin and prominent nucleoli. A
wide panel of IHC makers was performed to sort out a
diagnosis from an equally wide range of differentials,
including metastasis from a poorly differentiated carci-
noma, a rhabdomyosarcoma, a melanoma, an epithelioid
leiomyosarcoma, an epithelioid angiosarcoma, an epithe-
lioid malignant peripheral nerve sheath tumor (MPNST),
an epithelioid gastrointestinal stromal tumor (GIST), a
conventional ES, an anaplastic large cell lymphoma
(ALCL), a synovial sarcoma, an extra-renal rhabdoid
tumor and a mesothelioma. In the clinico-radiologic met-
astatic work-up, no definite mass was identified in the
solid organs as well as in the gastrointestinal (GI) tract. In
addition, CEA levels were found to be normal. No glandu-
lar or squamoid areas were seen in the tumor. Further, on
IHC, lack of CK20 and CEA expression made a possibility
of a metastatic adenocarcinoma from the GI tract as less
likely. CD 34 positivity further substantiated a diagnosis
of an ES over a carcinoma, as well as a synovial sarcoma,
the latter which is known to express epithelial and mesen-
chymal markers [5,6]. Apart from this dual immunoreac-
tivity, no biphasic tumor cell pattern was noted. Lack of S-
100 and HMB-45 ruled out the possibilities of an epithe-
lioid MPNST and a melanoma. Desmin was found to be
focally positive as has been seen by Guillou et al in 62.5%
of their cases of proximal-type ES [4]. Possibility of an epi-
thelioid rhabdomyosarcoma was discarded considering
strong immunoreactvity for CK, CK7 and EMA along with
Myo D-1 negativity. An epithelioid leiomyosarcoma was
ruled out in view of SMA negativity. An epithelioid GIST
seemed another differential, but lack of C-KIT was helpful
in considering this close differential diagnosis, less likely.
An interesting observation in the tumor was a 'pseudoan-
giosarcomatous' pattern, as has been noted in some cases
by Guillou et al [4]. Lack of CD31 ruled out the possibility
of an epithelioid angiosarcoma [7]. In addition, diffuse
EMA and CK expression helped in considering a diagnosis
of an epithelioid angiosarcomas as less likely, which can
rarely show focal expression for these markers [5]. Lack of
LCA along with diffuse positivity for CK ruled out an
ALCL. Apart from the non-contributory findings in terms
of any body cavity lesions, calretinin negativity ruled out
a mesothelioma. In this way, a diagnosis of proximal-type
ES was based on the presence of larger/rhabdoid cells in a
tumor, with an otherwise epithelioid morphology, exhib-
iting a polyphenotypic expression with mesenchymal
markers (vimentin, CD34); a myogenic marker (desmin)
along with epithelial markers (CK, CK7, EMA). There have
been infrequent studies and case reports on this tumor
[4,8-10]. Ultrastructurally, the rhabdoid cells noted in this
tumor have been found to be displaying paranuclear,
well-delineated filamentous aggregates, indenting the
nucleus eccentrically along with tonofilaments around
the cytoplasmic inclusion that in itself is a result of the fil-
amentous aggregates [4]. In view of lack of fresh tissue, we
could not perform an ultrastructural analysis. Neverthe-
Real-time B-mode high frequency USG findings of the recurrent lesion: An oval, hypoechoic solid lesion anteriosuperior to a  scar in the subcutaneous region of the right upper inner thigh Figure 1
Real-time B-mode high frequency USG findings of the recurrent lesion: An oval, hypoechoic solid lesion anteriosuperior to a 
scar in the subcutaneous region of the right upper inner thigh.World Journal of Surgical Oncology 2007, 5:28 http://www.wjso.com/content/5/1/28
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less, the distinct cytoplasmic inclusions were well noted
on conventional staining. The 'rhabdoid' histology has
been seen in carcinomas and melanomas [11]. In cases of
proximal-type ES, it forms an intrinsic part of the tumor
morphology. However, its prognostic significance
remains unclear [8]. Another close differential, which was
entertained, was the rhabdoid tumor itself. In terms of its
biological behavior, like its renal counterpart, an extra-
renal rhabdoid tumor (ER RT) is quite aggressive and
lethal. However, it is commonly known to occur in
younger children. An ER RT shows inactivating muta-
tions/deletions of both the alleles of tumor suppresser
genes hSNF5/IN11 on chromosome 22q11.2 [12]. Similar
deletion has also been noted in proximal-type ES [13]. It
has been proposed that considering the aberrations on
chromosome 22 as an epiphenomenon, proximal-type ES
might be actually representing a form of a "complex"
rhabdoid tumor [12]. There have been few studies dealing
with the genetics of this subtype of ES, including a recent
case report by Lee et al [14], who reported chromosomal
gains of 5q32-qter, 12q24qter, and 22q by comparative
genomic hybridization in this tumor.
The importance of identifying this subtype lies in its
aggressive behavior was seen in our patient who, despite
adjuvant CT/RT did not get rid of the local lesion.
Although, fortunately he did not develop any metastatic
lesions in view of the adjuvant treatment, the persistence
of the tumor suggests a possibility of unclear margins of
the first excision that was performed elsewhere.
Proximal-type epithelioid sarcoma of perineum Figure 2
Proximal-type epithelioid sarcoma of perineum. 2A. Tumor cells showing compact sheets of polygonal cells. Focal tumoral 
necrosis noted. H&E × 200. 2B. Sheets of large cells with occasional intracytoplasmic inclusions (inset) and little intervening 
stroma. H&E × 400. 2C. A 'pseudoangiosarcomatous' pattern. Tumor cells arranged in a disintegrating perivascular pattern. 
H&E × 400. 2D. Prominent multi nodular pattern of tumor. Reticulin silver stain × 100.World Journal of Surgical Oncology 2007, 5:28 http://www.wjso.com/content/5/1/28
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IHC results Figure 3
IHC results. 3A. Tumor cells displaying positive immunoreactivity for CK7. DAB × 400. 3B. Tumor cells displaying strong 
membranous positivity for EMA. DAB × 200. 3C. Tumor cells showing intra cytoplasmic dot-like expression for desmin. DAB 
× 400. 3D. Strong, diffuse, membranous positivity for CD34. DAB × 400. Positive internal control in the vascular endothelial 
cells noted.
Table 1: List of the various primary antibody markers
Antigen Type Dilution Antigen retrieval Source
Vimentin Monoclonal 1:50 Microwave Dako, Produkionsveg, 
Glostrup, Denmark
Cytokeratin (CK) Monoclonal 1:100 Pronase (Enzymatic) Dako
CK 7 Monoclonal 1:50 Microwave Dako
Epithelial membrane 
antigen (EMA)
Monoclonal 1:100 Pepsin (Enzymatic) Dako
Desmin Monoclonal 1:50 Microwave Dako
CD34 Monoclonal 1:100 Microwave Dako
Smooth muscle actin 
(SMA)
Monoclonal 1:200 Pepsin (Enzymatic) Dako
CK20 Monoclonal 1:100 Microwave Dako
Carcinoembryonic antigen 
(CEA)
Polyclonal 1:400 Pepsin (Enzymatic) Dako
S-100 Polyclonal 1:300 Pepsin (Enzymatic) Dako
Myo D-1 Monoclonal 1:20 Pressure cooker and EDTA Dako
HMB-45 Monoclonal 1:50 Microwave Dako
Leukocyte common 
antigen (LCA)
Monoclonal 1:100 Microwave Dako
C-KIT Polyclonal 1:100 Microwave Dako
Calretinin Monoclonal 1:50 Microwave Dako
CD31 Monoclonal 1:40 Microwave DakoPublish with BioMed Central    and   every 
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Certain prognostic factors, including tumor size have
been recognized in proximal-type ES [8]. Current accumu-
lated data indicate that the presence of rhabdoid features
in malignant tumors is related to an aggressive behavior,
multimodal therapy resistance, a rapidly fatal outcome. At
the same time it has been postulated that whether this
grim prognosis is related to rhabdoid vs non-rhabdoid
cell ratio with in the tumor is unclear [11,15,16]. In our
case, the recurrent mass revealed an increase in the
number of larger cells. It would be worthwhile to identify
more of such cases clinical outcomes. Further, genetic
studies would be helpful in establishing insights into the
molecular events responsible for the polyphenotypic
expression of this tumor with an uncertain differentiation.
Conclusion
The importance of identifying this tumor relates to its
aggressive behavior. A range of differentials needs to be
kept and ruled out on the basis of the clinical profile, mor-
phology and a wide panel of relevant IHC markers. A
timely diagnosis, optimal treatment in form of a wide-
excision with clear margins and a close-follow up can be
helpful in anticipating recurrences and a fatal outcome
that can be seen with this aggressive tumor.
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